Search - tctmd.com

Displaying 1 - 20 of 62

Sort: Relevancy | Date

Presentation TCT 2016

WATCHMAN US POST-APPROVAL STUDY: Multicenter, Prospective, Registry Results With a Left Atrial Appendage Closure Device for Stroke Prevention in Patients With Atrial Fibrillation

Presenter: Martin B. Leon, Louis A. Cannon, David R. Holmes Jr.

November 02, 2016

Presentation TCT 2016

Special Tips and Tricks for LAA Closure Using the Watchman LAA Occluder

Presenter: Krzysztof Bartus, Saibal Kar

November 01, 2016

Presentation TCT 2016

TCT 26: Long-term Event Rates for Left Atrial Appendage Closure With WATCHMAN: PROTECT AF Five-Year and PREVAIL Three-Year Follow-up

Presenter: Zahid Amin, Jacqueline Saw, Vivek Y. Reddy

October 31, 2016

Presentation TCT 2016

Use of Watchman in Anticoagulant Contraindicated Patients: Has Safety and Efficacy Been Proven?

Presenter: Vivek Y. Reddy, Steven J. Yakubov, David R. Holmes Jr.

October 30, 2016

Presentation TCT 2016

Meta-analysis and Synthesis of Watchman Trials: Relative Safety and Efficacy vs Warfarin and NOACs in Anticoagulant Indicated Patients (Including Cost-effectiveness)

Presenter: Vivek Y. Reddy, Steven J. Yakubov

October 30, 2016

Presentation EuroPCR 2016

EWOLUTION: 3-months outcome of Left Atrial Appendage Closure with the WATCHMAN device in Europe

Presenter: Martin Bergmann

May 18, 2016

Presentation TCT 2015

Procedural Complications With Watchman: Case Examples

Presenter: Maurice Buchbinder, Zoltan G. Turi, Michael J. Rinaldi

October 13, 2015

Presentation TCT 2015

Complex LAA Closure With Watchman

Presenter: Maurice Buchbinder, Zoltan G. Turi, Matthew J. Price

October 13, 2015

Presentation TCT 2015

Preprocedural Planning for the Watchman Device: Case Examples

Presenter: Maurice Buchbinder, Zoltan G. Turi, Shephal Doshi

October 13, 2015

Presentation TCT 2015

Watchman Generation 5 (Watchman Flex)

Presenter: Brij Maini, Horst Sievert

October 12, 2015

Presentation TCT 2015

Watchman Step-by-Step

Presenter: Maurice Buchbinder, Brian K. Whisenant, Mark Reisman

October 12, 2015

Presentation TCT 2015

Step-by-Step Review of LAA Procedures (Watchman and Lariat)

Presenter: Russell A. Brandwein, Steven J. Yakubov

October 11, 2015

Presentation TCT 2015

Comprehensive Analysis of the Watchman Data: PROTECT AF, CAP, and PREVAIL

Presenter: Reda Ibrahim, Matthew J. Price, David R. Holmes Jr.

October 11, 2015

Presentation

LAA Closure: First in Man With the Fourth-Generation Watchman Device

Presenter: J. Ledwoch

September 15, 2015

Presentation CICT 2015

LAA Closure with the Watchman Device: Tips & Tricks to Optimize Success

Presenter: Horst Sievert

August 01, 2015

Presentation CICT 2015

Patient Selection for the Watchman Device: The European Perspective

Presenter: Horst Sievert

August 01, 2015

Presentation CICT 2015

Watchman Patient Selection: US Perspective

Presenter: Ted Feldman

July 31, 2015

Presentation TCT 2014

TCT 175: Preclinical Study of the Novel Generation of Watchman for Left Atrial Appendage Occlusion

Presenter: Josep Rodés-Cabau, Peter B Sick, Krzysztof Bartus, Dongming Hou

September 16, 2014

Presentation TCT 2014

Watchman Step-by-Step

Presenter: Saibal Kar, Horst Sievert, Jochen Wöhrle

September 16, 2014

Presentation TCT 2014

TCT 176: Comparison of Imputed Placebo Versus Observed Ischemic Stroke Rates in the Watchman Trials Shows a Significant Reduction in Risk

Presenter: John M. Lasala, Stuart J. Pocock, George Hanzel, MD

September 16, 2014

Advertisement

WATCHMAN US POST-APPROVAL STUDY: Multicenter, Prospective, Registry Results With a Left Atrial Appendage Closure Device for Stroke Prevention in Patients With Atrial Fibrillation

Special Tips and Tricks for LAA Closure Using the Watchman LAA Occluder

TCT 26: Long-term Event Rates for Left Atrial Appendage Closure With WATCHMAN: PROTECT AF Five-Year and PREVAIL Three-Year Follow-up

Use of Watchman in Anticoagulant Contraindicated Patients: Has Safety and Efficacy Been Proven?

Meta-analysis and Synthesis of Watchman Trials: Relative Safety and Efficacy vs Warfarin and NOACs in Anticoagulant Indicated Patients (Including Cost-effectiveness)

EWOLUTION: 3-months outcome of Left Atrial Appendage Closure with the WATCHMAN device in Europe

Procedural Complications With Watchman: Case Examples

Complex LAA Closure With Watchman

Preprocedural Planning for the Watchman Device: Case Examples

Watchman Generation 5 (Watchman Flex)

Watchman Step-by-Step

Step-by-Step Review of LAA Procedures (Watchman and Lariat)

Comprehensive Analysis of the Watchman Data: PROTECT AF, CAP, and PREVAIL

LAA Closure: First in Man With the Fourth-Generation Watchman Device

LAA Closure with the Watchman Device: Tips & Tricks to Optimize Success

Patient Selection for the Watchman Device: The European Perspective

Watchman Patient Selection: US Perspective

TCT 175: Preclinical Study of the Novel Generation of Watchman for Left Atrial Appendage Occlusion

Watchman Step-by-Step

TCT 176: Comparison of Imputed Placebo Versus Observed Ischemic Stroke Rates in the Watchman Trials Shows a Significant Reduction in Risk

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content